Literature DB >> 31614288

The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

William A Hall1, Eric S Paulson2, Uulke A van der Heide3, Clifton D Fuller4, B W Raaymakers5, Jan J W Lagendijk5, X Allen Li2, David A Jaffray6, Laura A Dawson6, Beth Erickson2, Marcel Verheij7, Kevin J Harrington8, Arjun Sahgal9, Percy Lee10, Parag J Parikh11, Michael F Bassetti12, Clifford G Robinson13, Bruce D Minsky14, Ananya Choudhury15, Robert J H A Tersteeg5, Christopher J Schultz2.   

Abstract

Radiation therapy (RT) is an essential component of effective cancer care and is used across nearly all cancer types. The delivery of RT is becoming more precise through rapid advances in both computing and imaging. The direct integration of magnetic resonance imaging (MRI) with linear accelerators represents an exciting development with the potential to dramatically impact cancer research and treatment. These impacts extend beyond improved imaging and dose deposition. Real-time MRI-guided RT is actively transforming the work flows and capabilities of virtually every aspect of RT. It has the opportunity to change entirely the delivery methods and response assessments of numerous malignancies. This review intends to approach the topic of MRI-based RT guidance from a vendor neutral and international perspective. It also aims to provide an introduction to this topic targeted towards oncologists without a speciality focus in RT. Speciality implications, areas for physician education and research opportunities are identified as they are associated with MRI-guided RT. The uniquely disruptive implications of MRI-guided RT are discussed and placed in context. We further aim to describe and outline important future changes to the speciality of radiation oncology that will occur with MRI-guided RT. The impacts on RT caused by MRI guidance include target identification, RT planning, quality assurance, treatment delivery, training, clinical workflow, tumour response assessment and treatment scheduling. In addition, entirely novel research areas that may be enabled by MRI guidance are identified for future investigation. Published by Elsevier Ltd.

Entities:  

Keywords:  Biologically guided radiation therapy; Elekta Unity; Image guidance; MR-guided radiation therapy; MRI and radiation therapy; Novel radiation technology; View ray

Mesh:

Year:  2019        PMID: 31614288      PMCID: PMC8447225          DOI: 10.1016/j.ejca.2019.07.021

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  77 in total

1.  Feasibility of MRI guided proton therapy: magnetic field dose effects.

Authors:  B W Raaymakers; A J E Raaijmakers; J J W Lagendijk
Journal:  Phys Med Biol       Date:  2008-09-17       Impact factor: 3.609

2.  Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.

Authors:  Marguerite Tyran; Naomi Jiang; Minsong Cao; Ann Raldow; James M Lamb; Daniel Low; Elaine Luterstein; Michael L Steinberg; Percy Lee
Journal:  Radiother Oncol       Date:  2018-08-30       Impact factor: 6.280

3.  The ViewRay system: magnetic resonance-guided and controlled radiotherapy.

Authors:  Sasa Mutic; James F Dempsey
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

4.  Dynamic contrast enhanced MRI monitoring of primary proton and carbon ion irradiation of prostate cancer using a novel hypofractionated raster scan technique.

Authors:  David Bonekamp; Maya B Wolf; Christopher Edler; Sonja Katayama; Heinz-Peter Schlemmer; Klaus Herfarth; Matthias Röthke
Journal:  Radiother Oncol       Date:  2016-05-26       Impact factor: 6.280

5.  A survey of image-guided radiation therapy use in the United States.

Authors:  Daniel R Simpson; Joshua D Lawson; Sameer K Nath; Brent S Rose; Arno J Mundt; Loren K Mell
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

6.  Technical Note: On the size of susceptibility-induced MR image distortions in prostate and cervix in the context of MR-guided radiation therapy.

Authors:  Julian Emmerich; Frederik B Laun; Asja Pfaffenberger; Rebecca Schilling; Michael Denoix; Florian Maier; Florian Sterzing; Tilman Bostel; Sina Straub
Journal:  Med Phys       Date:  2018-03-06       Impact factor: 4.071

7.  Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.

Authors:  Ying-Shi Sun; Xiao-Peng Zhang; Lei Tang; Jia-Fu Ji; Jin Gu; Yong Cai; Xiao-Yan Zhang
Journal:  Radiology       Date:  2009-12-17       Impact factor: 11.105

8.  Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.

Authors:  Daniel A Hamstra; Craig J Galbán; Charles R Meyer; Timothy D Johnson; Pia C Sundgren; Christina Tsien; Theodore S Lawrence; Larry Junck; David J Ross; Alnawaz Rehemtulla; Brian D Ross; Thomas L Chenevert
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

9.  The Role of Intravoxel Incoherent Motion MRI in Predicting Early Treatment Response to Chemoradiation for Metastatic Lymph Nodes in Nasopharyngeal Carcinoma.

Authors:  Liyan Lu; Yuehua Li; Wenbin Li
Journal:  Adv Ther       Date:  2016-06-13       Impact factor: 3.845

10.  Correlation of ADC With Pathological Treatment Response for Radiation Therapy of Pancreatic Cancer.

Authors:  Entesar Dalah; Beth Erickson; Kiyoko Oshima; Diane Schott; William A Hall; Eric Paulson; An Tai; Paul Knechtges; X Allen Li
Journal:  Transl Oncol       Date:  2018-02-20       Impact factor: 4.243

View more
  40 in total

Review 1.  Artificial intelligence in radiotherapy.

Authors:  Sarkar Siddique; James C L Chow
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-06

Review 2.  The role of radiomics in prostate cancer radiotherapy.

Authors:  Rodrigo Delgadillo; John C Ford; Matthew C Abramowitz; Alan Dal Pra; Alan Pollack; Radka Stoyanova
Journal:  Strahlenther Onkol       Date:  2020-08-21       Impact factor: 3.621

Review 3.  A half-century of innovation in technology-preparing MRI for the 21st century.

Authors:  Peter Börnert; David G Norris
Journal:  Br J Radiol       Date:  2020-06-15       Impact factor: 3.039

Review 4.  Evolving Concepts Regarding Radiation Therapy for Pancreatic Cancer.

Authors:  William A Hall; Beth Erickson; Christopher H Crane
Journal:  Surg Oncol Clin N Am       Date:  2021-10       Impact factor: 2.402

5.  Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.

Authors:  Rachel W Chan; Hanbo Chen; Sten Myrehaug; Eshetu G Atenafu; Greg J Stanisz; James Stewart; Pejman Jabehdar Maralani; Aimee K M Chan; Shadi Daghighi; Mark Ruschin; Sunit Das; James Perry; Gregory J Czarnota; Arjun Sahgal; Angus Z Lau
Journal:  J Neurooncol       Date:  2020-11-16       Impact factor: 4.130

Review 6.  A narrative review of MRI acquisition for MR-guided-radiotherapy in prostate cancer.

Authors:  Jing Yuan; Darren M C Poon; Gladys Lo; Oi Lei Wong; Kin Yin Cheung; Siu Ki Yu
Journal:  Quant Imaging Med Surg       Date:  2022-02

7.  Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac.

Authors:  Jihong Wang; Travis Salzillo; Yongying Jiang; Yuri Mackeyev; Clifton David Fuller; Caroline Chung; Seungtaek Choi; Neil Hughes; Yao Ding; Jinzhong Yang; Sastry Vedam; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2021-06-03       Impact factor: 6.901

Review 8.  Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions.

Authors:  William A Hall; Christina Small; Eric Paulson; Eugene J Koay; Christopher Crane; Martijn Intven; Lois A Daamen; Gert J Meijer; Hanne D Heerkens; Michael Bassetti; Stephen A Rosenberg; Katharine Aitken; Sten Myrehaug; Laura A Dawson; Percy Lee; Cihan Gani; Michael David Chuong; Parag J Parikh; Beth A Erickson
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 5.738

9.  Implementation of Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) for Hepatobiliary and Pancreatic Cancers in the United Kingdom - Fifty in Five.

Authors:  Andrew Gaya; Philip Camilleri; Adam Nash; Donna Hughes; James Good
Journal:  Cureus       Date:  2021-05-17

10.  Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group.

Authors:  Petra J van Houdt; Hina Saeed; Daniela Thorwarth; Clifton D Fuller; William A Hall; Brigid A McDonald; Amita Shukla-Dave; Ernst S Kooreman; Marielle E P Philippens; Astrid L H M W van Lier; Rick Keesman; Faisal Mahmood; Catherine Coolens; Teodor Stanescu; Jihong Wang; Neelam Tyagi; Andreas Wetscherek; Uulke A van der Heide
Journal:  Eur J Cancer       Date:  2021-06-15       Impact factor: 10.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.